Advanced Medical Solutions Grp PLC
18 January 2000
Winsford, 18 January 2000. Advanced Medical Solutions Group plc., (AMS),
today announced that Donald Evans, currently Managing Director of the Advanced
Woundcare division and a Director of the Company will assume the role of Chief
Executive with immediate effect.
Roy Smith, the current Chief Executive, has indicated that it is his intention
to resign from the Board of Directors and the Company at the AGM. Don and Roy
will work closely together over the intervening period to facilitate the
transition.
James Noble, Chairman, commented: 'We are pleased to have a Director of the
calibre of Don Evans to assume the role of Chief Executive. His experience
will ensure that the process of commercialisation, begun by Roy, will
continue'.
He added, 'AMS will continue to invest to exploit growth opportunities offered
by the consumer woundcare market and to seek additional marketing partners for
its innovative product range. In addition, maximising the commercial
potential of the Group's core polymer technology remains a high priority'.
For further information, please contact:
Advanced Medical Solutions Group plc
Don Evans (Chief Executive Officer) Tel: 01606 863500
Gavin Anderson & Company
Philip Ward Tel: 0171 457 2345
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.